Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole.

Abstract

Rifaximin showed an higher SIBO decontamination rate than metronidazole at the tested doses, both with a significant gain in terms of tolerability. Either the present study or recent evidencies suggest that rifaximin represents a good choice for the management of patients affected by SIBO.